retatrutide the same as mounjaro (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. reason comes down to how it works Retatrutide vs Mounjaro: Which Weight
Description
Comparing the cost of insulin treatment in Canada and the United States

But another conversation has begun gaining momentum centered on fiber and the gut microbiome.

Recently reported by BioSpace, new research highlights the expanding benefits of GLP-1 medications beyond weight loss and diabetes management

GLP-1 S is a GLP-1 receptor agonist the same class behind today's leading weight-management research studied for appetite control, blood-sugar

The airball comes as Novo scrambles to regain a majority share of the GLP-1 market.

Ahead of the Trump administrations planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicares negotiated price for certain GLP-1 products beginning in 2027, this analysis examines CMSs Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being treated with GLP-1 drugs and the growth in Medicare spending and claims for these drugs.